Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults - PubMed (original) (raw)
Comparative Study
Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults
Preetha Rajaraman et al. Cancer Epidemiol Biomarkers Prev. 2007 Aug.
Abstract
Despite the potential importance of the cell cycle and apoptosis pathways in brain tumor etiology, little has been published regarding brain tumor risk associated with common gene variants in these pathways. Using data from a hospital-based case-control study conducted by the National Cancer Institute between 1994 and 1998, we evaluated risk of glioma (n = 388), meningioma (n = 162), and acoustic neuroma (n = 73) with respect to 12 single nucleotide polymorphisms from 10 genes involved in apoptosis and cell cycle control: CASP8, CCND1, CCNH, CDKN1A, CDKN2A, CHEK1, CHEK2, MDM2, PTEN, and TP53. We observed significantly decreased risk of meningioma with the CASP8 Ex14-271A>T variant [odds ratio (OR)(AT), 0.8; 95% confidence interval (95% CI), 0.5-1.2; OR(AA), 0.5; 95% CI, 0.3-0.9; P(trend) = 0.03] and increased risk of meningioma with the CASP8 Ex13+51G>C variant (OR(GC), 1.4; 95% CI, 0.9-2.1; OR(CC), 3.6; 95% CI, 1.0-13.1; P(trend) = 0.04). The CT haplotype of the two CASP8 polymorphisms was associated with significantly increased risk of meningioma (OR, 1.7; 95% CI, 1.1-2.6), but was not associated with risk of glioma or acoustic neuroma. The CCND1 Ex4-1G>A variant was associated with increased risk for glioma, and the Ex8+49T>C variant of CCNH was associated with increased risk of glioma and acoustic neuroma. The MDM2 Ex12+162A>G variant was associated with significantly reduced risk of glioma. Our results suggest that common variants in the CASP8, CCND1, CCNH, and MDM2 genes may influence brain tumor risk. Future research in this area should include more detailed coverage of genes in the apoptosis/cell cycle control pathways.
Similar articles
- Distribution and Effects of CDKN2 p16 540 C>G and 580 C>T, and MDM2 SNP309 T>G Polymorphisms in Patients with Primary Brain Tumors.
Kafadar A, Küçükhüseyin Ö, Turan S, Yenilmez EN, Tunoglu S, Zeybek U, Kaynar MY, Kemerdere R, Yaylim I. Kafadar A, et al. Anticancer Res. 2015 Jul;35(7):3933-42. Anticancer Res. 2015. PMID: 26124340 - DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma.
Rajaraman P, Hutchinson A, Wichner S, Black PM, Fine HA, Loeffler JS, Selker RG, Shapiro WR, Rothman N, Linet MS, Inskip PD. Rajaraman P, et al. Neuro Oncol. 2010 Jan;12(1):37-48. doi: 10.1093/neuonc/nop012. Epub 2009 Dec 10. Neuro Oncol. 2010. PMID: 20150366 Free PMC article. - Analysis of CASP8 D302H Gene Variants in Patients with Primary Brain Tumors.
Cacina C, Pence S, Turan S, Genc F, Ozdemir H, Kafadar A, Kaynar MY, Yaylim I. Cacina C, et al. In Vivo. 2015 Sep-Oct;29(5):601-4. In Vivo. 2015. PMID: 26359420 - Tumor suppressor genes in breast cancer: the gatekeepers and the caretakers.
Oliveira AM, Ross JS, Fletcher JA. Oliveira AM, et al. Am J Clin Pathol. 2005 Dec;124 Suppl:S16-28. doi: 10.1309/5XW3L8LU445QWGQR. Am J Clin Pathol. 2005. PMID: 16468415 Review. - The functional role of tumor suppressor genes in gliomas: clues for future therapeutic strategies.
Fueyo J, Gomez-Manzano C, Yung WK, Kyritsis AP. Fueyo J, et al. Neurology. 1998 Nov;51(5):1250-5. doi: 10.1212/wnl.51.5.1250. Neurology. 1998. PMID: 9818841 Review.
Cited by
- Caspase 8 Expression Patterns in Meningiomas: A Tissue Microarray Digital Image Analysis.
Roukas D, Kouzoupis A, Spyropoulou D, Tsiambas E, Mastronikolis S, Falidas E, Tsouvelas G, Ragos V, Lazaris AC, Kavantzas N. Roukas D, et al. Cureus. 2022 Jun 21;14(6):e26182. doi: 10.7759/cureus.26182. eCollection 2022 Jun. Cureus. 2022. PMID: 35891812 Free PMC article. - Genetic variant in CASP3 affects promoter activity and risk of esophageal squamous cell carcinoma.
Zhang Z, Yu X, Guo Y, Song W, Yu D, Zhang X. Zhang Z, et al. Cancer Sci. 2012 Mar;103(3):555-60. doi: 10.1111/j.1349-7006.2011.02173.x. Epub 2012 Jan 9. Cancer Sci. 2012. PMID: 22136337 Free PMC article. - Association between XRCC3 Thr241Met polymorphism and risk of brain tumors: a meta-analysis.
Liu J, Zhou Z, Lai T, Yin J. Liu J, et al. Tumour Biol. 2014 Feb;35(2):1083-7. doi: 10.1007/s13277-013-1144-x. Epub 2013 Sep 6. Tumour Biol. 2014. PMID: 24061639 - Association between the G870A polymorphism of Cyclin D1 gene and glioma risk.
Zong H, Cao L, Ma C, Zhao J, Ming X, Shang M, Xu H. Zong H, et al. Tumour Biol. 2014 Aug;35(8):8095-101. doi: 10.1007/s13277-014-1981-2. Epub 2014 May 20. Tumour Biol. 2014. PMID: 24840634 - Frequency of polymorphisms and protein expression of cyclin-dependent kinase inhibitor 1A (CDKN1A) in central nervous system tumors.
Valentin MD, Canalle R, Queiroz Rde P, Tone LG. Valentin MD, et al. Sao Paulo Med J. 2009 Sep;127(5):288-94. doi: 10.1590/s1516-31802009000500008. Sao Paulo Med J. 2009. PMID: 20169278 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous